Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 October 2024 | Story Jacky Tshokwe | Photo Bram Fischer
BRAM FISCHER MEMORIAL LECTURE 2024

Join us as Prof Premesh Lalu from the University of the Western Cape presents this year’s lecture, with a response from Prof Steven Friedman of the University of Johannesburg.

Lecture title: "Bram Fischer's Briefcase: What's Left of Apartheid?"

In a compelling narrative of historical irony, a briefcase exchanged between Bram Fischer and Sydney Kentridge after the Rivonia Trial was later reimagined in the 1997 theatre production Ubu and the Truth Commission, created by Jane Taylor, William Kentridge, and Handspring Puppet Company. Repurposed as the ‘Dogs of War’ puppet, this briefcase transformed into Brutus, Brutus, and Brutus – embodying apartheid’s enforcers and the unspoken tensions beneath South Africa's political history. Through the theatre lens, the lecture will explore whether Bram Fischer’s briefcase revealed apartheid as a tragicomedy that needed dismantling to foster genuine reconciliation.

Date: Thursday 14 November 2024
Time: 18:00 to 21:00

Venue: Albert Wessels Auditorium, UFS Bloemfontein Campus

Click to view documentClick here to RSVP before by 10 November 2024.

The Speaker

Prof Premesh Lalu is a prominent researcher and former Director of the Centre for Humanities Research (CHR) at the University of the Western Cape, which was awarded flagship status by the Department of Science and Innovation (DSTI) and the National Research Foundation (NRF) in 2016. His books include The Deaths of Hintsa: Post-Apartheid South Africa and the Shape of Recurring Pasts (2009) and Undoing Apartheid (2022). He is a respected voice in publications such as History and Theory, the Journal of Southern African Studies, and Critical Times, and serves on various international advisory boards.

The Respondent

Prof Steven Friedman is a Research Professor in the Faculty of Humanities at the University of Johannesburg. A widely published authority on South Africa’s democratic transition, his work focuses on democratic theory and practice. His notable publications include Good Jew, Bad Jew: Racism, Anti-Semitism and the Assault on Meaning, and he writes a weekly column, Against the Tide, offering critical insights into South African democracy.

For further information, please contact Alicia Pienaar at pienaaran1@ufs.ac.za.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept